Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 58, n° 3
pages 488-489 (mars 2008)
Doi : 10.1016/j.jaad.2006.07.001
Case Reports

Sweet’s syndrome–like neutrophilic dermatosis resulting from exposure to a radiocontrast agent

Yossef Alper, MD, Eli Sprecher, MD, PhD, Reuven Bergman, MD , Rachel Friedman Birnbaum, MD
Department of Dermatology, Rambam Medical Center, and Technion-Israel Institute of Technology, Bruce Rappaport Faculty of Medicine, Haifa, Israel 

Reprint requests: Reuven Bergman, MD, Department of Dermatology, Rambam Medical Center, PO Box 9602, Haifa 31096, Israel.

Radiocontrast agents are known to be the cause of many cutaneous manifestations. The present report describes a unique case of a Sweet’s syndrome–like neutrophilic dermatosis that recurred three times over 5 years following administration of a radiocontrast agent administered during the course of an intravenous pyelography.

The full text of this article is available in PDF format.

 Funding sources: None.
 Conflicts of interest: None declared.

© 2008  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline